Strong immunostaining for myogenin in rhabdomyosarcoma is significantly associated with tumors of the alveolar subclass.
about
Mechanisms of impaired differentiation in rhabdomyosarcomaA comparative review of canine and human rhabdomyosarcoma with emphasis on classification and pathogenesisAlveolar rhabdomyosarcoma of nasopharynx and paranasal sinuses with metastasis to breast in a middle-aged woman: a case report and literature reviewAberrant expression of epithelial and neuroendocrine markers in alveolar rhabdomyosarcoma: a potentially serious diagnostic pitfall.Myogenin, AP2β, NOS-1, and HMGA2 are surrogate markers of fusion status in rhabdomyosarcoma: a report from the soft tissue sarcoma committee of the children's oncology group.Immunohistochemical quantification of the vitamin B12 transport protein (TCII), cell surface receptor (TCII-R) and Ki-67 in human tumor xenografts.Immunohistochemistry as an important tool in biomarkers detection and clinical practice.Spindle cell rhabdomyosarcoma of the retroperitoneum: an unusual case developed in a pregnant woman but obscured by pregnancy.Pathologic classification of rhabdomyosarcomas and correlations with molecular studies.Myogenin and MyoD1 expression in paediatric rhabdomyosarcomas.Immunohistochemistry in the diagnosis of soft tissue tumours.MURC/cavin-4 Is Co-Expressed with Caveolin-3 in Rhabdomyosarcoma Tumors and Its Silencing Prevents Myogenic Differentiation in the Human Embryonal RD Cell Line.Role of the YAP Oncoprotein in Priming Ras-Driven Rhabdomyosarcoma.Childhood rhabdomyosarcoma: recent advances and prospective views.Head and Neck Rhabdomyosarcoma: Clinical and Pathologic Characterization of Seven Cases.Dense pattern of embryonal rhabdomyosarcoma, a lesion easily confused with alveolar rhabdomyosarcoma: a report from the Soft Tissue Sarcoma Committee of the Children's Oncology GroupFOXO1a acts as a selective tumor suppressor in alveolar rhabdomyosarcoma.Time courses of growth and remodeling of porcine aortic media during hypertension: a quantitative immunohistochemical examinationAlveolar rhabdomyosarcoma - The molecular drivers of PAX3/7-FOXO1-induced tumorigenesisSurvivin-directed RNA interference cocktail is a potent suppressor of tumour growth in vivoRhabdomyosarcoma subtyping by immunohistochemical assessment of myogenin: tissue array study and review of the literature.Primary pulmonary rhabdomyosarcoma in an adult: a case report and review of the literatureDiagnostic and prognostic sarcoma signatures.Myogenic tumors in children and adolescents.Rhabdomyoblastic Differentiation in Head and Neck Malignancies Other Than Rhabdomyosarcoma.Round cell sarcoma with CIC-DUX4 gene fusion: Discussion of the distinctive cytomorphologic, immunohistochemical, and molecular features in the differential diagnosis of round cell tumors.Detection of FOXO1 break-apart status by fluorescence in situ hybridization in atypical alveolar rhabdomyosarcoma.Impact of fusion gene status versus histology on risk-stratification for rhabdomyosarcoma: Retrospective analyses of patients on UK trials.Glycogen synthase kinase 3β represses MYOGENIN function in alveolar rhabdomyosarcoma.Anaplastic lymphoma kinase status in rhabdomyosarcomas.Clinical utility gene card for: Alveolar rhabdomyosarcoma.Identification of a new class of PAX3-FKHR target promoters: a role of the Pax3 paired box DNA binding domainEffect of biomaterial properties on bone healing in a rabbit tooth extraction socket model.Therapeutic cytodifferentiation in alveolar rhabdomyosarcoma without genetic change of the PAX3-FKHR chimeric fusion gene: a case study.Adult cutaneous alveolar rhabdomyosarcoma on the face diagnosed by the expression of PAX3-FKHR gene fusion transcripts.Rhabdomyosarcoma of the breast: Report of a rare malignancy.Sinonasal Tract Alveolar Rhabdomyosarcoma in Adults: A Clinicopathologic and Immunophenotypic Study of Fifty-Two Cases with Emphasis on Epithelial Immunoreactivity.Huge cranio-cerebral rhabdomyosarcoma in HIV-positive patient.Pleomorphic rhabdomyosarcoma in adults: a clinicopathologic study of 38 cases with emphasis on morphologic variants and recent skeletal muscle-specific markers.Spindle cell rhabdomyosarcoma in adults: clinicopathological and immunohistochemical analysis of seven new cases.
P2860
Q26852728-ACEF1D23-918A-4A90-B30F-48F32773027DQ26852801-9C67AC40-4D31-4F7A-8891-658CC3AB949BQ28067923-0B6460D7-366F-4F3A-B32E-FFF6550DCD76Q30843609-F7E97058-5756-40C6-81A2-FF85DA87AC28Q33567593-CAAAD1EB-7934-42B3-91D3-C7D2AA2CFFAFQ33702468-1C82E0AC-3E6E-4F94-9D8A-E6DFCFE58286Q33704442-4A86D487-5033-4F6E-B4AB-5D26556783D4Q34121419-1A9561DD-9FB5-4644-8119-280E26476EE5Q34250993-04615359-8E3C-4A64-AA56-C09BF3724A85Q35144171-B455E855-D225-44F4-B8BE-D85676E3E96BQ35161409-DBA7BCF3-D2CF-4129-9BEB-7C208DEA5B22Q35667137-8957E1D0-C705-492A-9D85-3CD7064174C7Q35819280-24A59B8E-C815-4666-8A28-AE2BB7406DFFQ35847829-820CC1C9-3993-49B8-9865-D9C5633909FEQ36206424-F5646061-7066-493D-8734-34A6053F2853Q36219115-324B78DE-8F9F-41DF-86E8-18DFA24E3618Q36320889-A3C8CE58-B42C-436C-8F5B-0FCA25992872Q36574287-07DB2806-24CE-40FC-8C9E-F976B8380F52Q36588372-FF3DAFD2-B292-4FD8-BE00-D4D1B43C9189Q36930279-92FC2F2B-A384-4318-A3D9-51BDDF0553B0Q37169172-03D84CF4-90C3-4CDA-AD5E-0E356BEBFA83Q37172346-30A2CFEC-1418-4ABD-A8DF-E2979C06F5D7Q37335373-74A80DC4-8A87-4495-BA5D-321A417BD3FCQ37993928-DFBBE907-6DA1-4852-A2E8-8A36881ACE94Q38372544-F2AC3939-0A3F-45AC-A1B0-4D070F82E032Q38708033-EB085FB4-937C-4CDB-9E5E-C7F38BB6CCD3Q38711061-109915BE-280B-43AE-8F81-58F7E3006996Q38776314-956BDC07-5ACB-4A08-BF91-BBBEA1AC4C92Q39020234-93F7972F-36C8-4D77-A085-61D1DF76CB21Q39487924-F282DF84-982A-4F52-93AC-00BE5BC16D97Q39701226-539CCF0A-C72E-4A2B-9487-4FEE97A12FA5Q42703157-AA4849D3-258F-41FC-82AB-32B11F2327CDQ44755798-EF64F78D-5BB4-4524-B7E7-9319B836C503Q45895047-39BEB451-4183-48E0-AC55-FB5F0C1B7170Q46427632-643D989D-5029-4363-8BC6-2B0AE100D4F7Q47670945-8FD02109-A81E-40E7-9649-63C15494EB93Q47850677-68EAE9F8-4332-46BD-AFB6-93985C5BCF09Q48289245-62A21C73-FA0A-4CD7-8A56-CFD1C54ABFB1Q50505025-CF237769-6974-4BCA-A2D1-D7B122EF04EFQ51782992-61DBA31D-8B77-4AA0-820C-EFD871552103
P2860
Strong immunostaining for myogenin in rhabdomyosarcoma is significantly associated with tumors of the alveolar subclass.
description
2000 nî lūn-bûn
@nan
2000年の論文
@ja
2000年論文
@yue
2000年論文
@zh-hant
2000年論文
@zh-hk
2000年論文
@zh-mo
2000年論文
@zh-tw
2000年论文
@wuu
2000年论文
@zh
2000年论文
@zh-cn
name
Strong immunostaining for myog ...... mors of the alveolar subclass.
@ast
Strong immunostaining for myog ...... mors of the alveolar subclass.
@en
type
label
Strong immunostaining for myog ...... mors of the alveolar subclass.
@ast
Strong immunostaining for myog ...... mors of the alveolar subclass.
@en
prefLabel
Strong immunostaining for myog ...... mors of the alveolar subclass.
@ast
Strong immunostaining for myog ...... mors of the alveolar subclass.
@en
P2093
P2860
P1476
Strong immunostaining for myog ...... mors of the alveolar subclass.
@en
P2093
J Thompson
P Houghton
P2860
P304
P356
10.1016/S0002-9440(10)64743-8
P407
P577
2000-02-01T00:00:00Z